Anzeige
Erschienen in:
2018 | OriginalPaper | Buchkapitel
1. Innovation: Key to Success in the Pharmaceutical Industry
verfasst von : Oliver Gassmann, Alexander Schuhmacher, Max von Zedtwitz, Gerrit Reepmeyer
Erschienen in: Leading Pharmaceutical Innovation
Aktivieren Sie unsere intelligente Suche, um passende Fachinhalte oder Patente zu finden.
Wählen Sie Textabschnitte aus um mit Künstlicher Intelligenz passenden Patente zu finden. powered by
Markieren Sie Textabschnitte, um KI-gestützt weitere passende Inhalte zu finden. powered by
Abstract
The traditional model of innovation in the pharmaceutical industry is being challenged by an explosion of costs for R&D, a strengthened voice of the customer and regulatory bodies in the development of new medicines, and the vanishing of easy targets. An overview is given of established and emerging pharma companies, the cost structures for pharma innovation, and the nature of the productivity gap. We describe the blockbuster imperative and the pervasive concerns about risk and safety in pharma R&D, and conclude with a brief outlook on the main themes to be discussed in the remainder of the book.